CCCC - C4 Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$7.00
DETAILS
HIGH:
$7.00
LOW:
$7.00
MEDIAN:
$7.00
CONSENSUS:
$7.00
UPSIDE:
96.63%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-04-01 | Anderson Kenneth Carl | director | A-Award | 4,259 | $2.70 | $11K |
| 2026-04-01 | GROGAN DONNA ROY | director | A-Award | 5,370 | $2.70 | $14K |
| 2026-02-13 | Boyle Scott N | officer: Chief Business Officer | A-Award | 200,000 | -- | -- |
| 2026-02-13 | Boyle Scott N | officer: Chief Business Officer | M-Exempt | 5,000 | -- | -- |
| 2026-02-14 | Boyle Scott N | officer: Chief Business Officer | F-InKind | 7,269 | $1.89 | $14K |
| 2026-02-14 | Mahaney Paige | officer: Chief Scientific Officer | M-Exempt | 7,050 | -- | -- |
| 2026-02-13 | Mahaney Paige | officer: Chief Scientific Officer | A-Award | 240,000 | -- | -- |
| 2026-02-14 | Hirsch Andrew | director, officer: President & CEO | M-Exempt | 81,725 | -- | -- |
| 2026-02-14 | Hirsch Andrew | director, officer: President & CEO | F-InKind | 39,154 | $1.89 | $74K |
| 2026-02-14 | REYNO LEONARD | officer: Chief Medical Officer | M-Exempt | 30,950 | -- | -- |
| 2026-02-13 | REYNO LEONARD | officer: Chief Medical Officer | A-Award | 240,000 | -- | -- |
| 2026-02-14 | REYNO LEONARD | officer: Chief Medical Officer | F-InKind | 16,579 | $1.89 | $31K |
| 2026-02-13 | Adams Kendra | officer: Chief Financial Officer | F-InKind | 1,863 | $1.89 | $4K |
| 2026-02-14 | Adams Kendra | officer: Chief Financial Officer | M-Exempt | 30,950 | -- | -- |
| 2026-02-14 | Adams Kendra | officer: Chief Financial Officer | F-InKind | 15,381 | $1.89 | $29K |
| 2026-02-14 | Mossler Mark | officer: Chief Accounting Officer | F-InKind | 3,268 | $1.89 | $6K |
| 2026-02-15 | Hirsch Andrew | director, officer: President & CEO | M-Exempt | 20,400 | -- | -- |
| 2026-02-13 | Mossler Mark | officer: Chief Accounting Officer | A-Award | 56,980 | -- | -- |
| 2026-02-14 | Mahaney Paige | officer: Chief Scientific Officer | F-InKind | 2,446 | $1.89 | $5K |
| 2026-02-14 | Mossler Mark | officer: Chief Accounting Officer | M-Exempt | 9,420 | -- | -- |
| 2026-02-14 | Boyle Scott N | officer: Chief Business Officer | M-Exempt | 20,950 | -- | -- |
| 2026-02-13 | Boyle Scott N | officer: Chief Business Officer | F-InKind | 1,735 | $1.89 | $3K |
| 2026-02-13 | Schick Kelly | officer: Chief People Officer | M-Exempt | 5,000 | -- | -- |
| 2026-02-15 | Hirsch Andrew | director, officer: President & CEO | F-InKind | 9,057 | $1.89 | $17K |
| 2026-02-13 | Adams Kendra | officer: Chief Financial Officer | A-Award | 240,000 | -- | -- |